Synaptogenix Inc (SNPX)

[Cyosol]

I seriously doubt management would want to raise any cash while the price is below fair market value acording to them.

Here's an excerpt from the 10-K:

"The following table sets forth the high and low closing bid prices for our common stock for the fiscal quarter indicated, as reported on The Nasdaq Capital Market beginning on March 29, 2017 and on the OTC Market prior to March 29, 2017. The quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions. Our common stock has historically been very thinly traded and, thus, pricing of our common stock on the OTC Market does not necessarily represent its fair market value."

Considering that the CEO was involved in developing Namenda, I'd like to think that he's smart enough to delay any further fundraising until after the new trials have commenced later this year. Any future feedback from the FDA will also most likely push up the stock price to more accurately reflect the true potential of Bryostatin.

Personally I think the smartest decision would be to just wait until confirmation trial results are announced before raising further funds, because then no one will be able to deny that this thing actually works.